2024年,昭衍新药营收同比下降15.07%,归母净利润同比下滑幅度高达81.34%投资时间网、标点财经研究员 李路近来,部分上市医药企业股价出现“跷跷板”现象,跷跷板的上端是AI医药企业,例如晶泰控股(02228.HK)、成都先导(688222.SH)等,这些企业股价飘红,涨幅在5%以上;跷跷板的下端是以北京昭衍新药研究中心股份有限公司(下称昭衍新药,603127.SH、06127.HK)为...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.